2nd Bioengineering & Translational Medicine Conference

Session: Immunoengineering

Presentations

01:00 PM

Vignettes on Engineering Targeted, Immunomodulatory Therapies

Michael Look

01:30 PM

Inhibition of Cancer Immune Suppression with a First-in-Class Engineered Therapeutic Enzyme

John Blazeck, Todd Triplett, Everett Stone, George Georgiou, Christos Karamitros, Kendra Garrison

01:45 PM

Engineering Robust T Cells for Cancer Immunotherapy

Yvonne Y. Chen

02:00 PM

Quantitative In Vivo & Ex Vivo Multimodality Cell Imaging of Antigen-Specific T-Cells in Murine Metastatic Ovarian Cancer

Matthew Willadsen, Iven Yarovoy, An Qi Zhang, Steven Turowski, Joseph Spernyak, Mukund Seshadri, A.J. Robert McGray, Kunle Odunsi, Natesh Parashurama

02:15 PM

Single-Cell Profiling Demonstrates That Migratory T Cells Demonstrate Superior Persistence and Enhanced Tumor Control

Navin Varadarajan

02:30 PM

Engineering Nanotechnologies for Immuno-Oncology: "Smart" Nanoparticles for Immunotherapeutic Targeting of the Sting Pathway

Daniel Shae, John T. Wilson, Sema Sevimli

02:45 PM

Direct Selection of Synthetic Binding Proteins That Recognize Post-Translationally Modified Proteins in Living Cells

Bunyarit Meksiriporn, Matthew DeLisa, Allen Jiang, Dujduan Waraho, Hyeon Cheol Lee

03:00 PM

Utilizing Oxygen-Inhibited Photopolymerization to Control Size of Multimodal PEGDA Hydrogel Nanoparticles for Cancer Therapeutics

Daniel Debroy, Dongmei Li, John Oakey